TENET HEALTHCARE CORP (THC) Stock News
NYSE:THC - New York Stock Exchange, Inc. - US88033G4073 - Common Stock - Currency: USD
THC Latest News, Press Relases and Analysis
Here's How Much $1000 Invested In Tenet Healthcare 15 Years Ago Would Be Worth Today
Is Tenet (THC) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for Tenet (THC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
Sector ETF report for FXH
RBC Sees Limited Exposure to Medicaid Risks for Tenet (THC), Reiterated $189 Target
Tenet Healthcare Corporation (NYSE:THC) is one of the 20 undervalued momentum stocks that are taking off. On June 11, RBC Capital analyst Ben Hendrix reiterated a Buy rating on Tenet Healthcare (THC), maintaining a price target of $189. The reaffirmation follows recent volatility in hospital stocks triggered by a White House memo regarding Medicaid supplemental payment […]
Tenet to Report its Second Quarter 2025 Results on July 22nd
DBS Raises Netflix (NFLX) Target Price on Subscriber Momentum, Maintains Buy
Netflix Inc. (NASDAQ:NFLX) is one of the 10 best tech stocks to buy according to billionaires right now. On Tuesday, June 10, media portal ‘Deadline Hollywood’ reported that Netflix’s Co-CEO Ted Sarandos has committed to invest around $1.0 billion on content creation in Spain by 2029. Sarandos, speaking at Netflix’s Tres Cantos Madrid hub, highlighted the strong […]
Tenet Healthcare (THC) Rises Higher Than Market: Key Facts
In the latest trading session, Tenet Healthcare (THC) closed at $166.26, marking a +0.97% move from the previous day.
Why Is Tenet (THC) Up 15.2% Since Last Earnings Report?
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mentions: UHS
Morgan Stanley Raises Tenet Healthcare (THC) PT to $210, Keeps Overweight Rating
Tenet Healthcare Corporation (NYSE:THC) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, Morgan Stanley raised its price target on Tenet Healthcare to $210 from $175, while maintaining an Overweight rating on the shares. Analyst Craig Hettenbach highlighted Tenet Healthcare as Morgan Stanley’s preferred stock within the hospital sector. […]
Morgan Stanley Initiates Centene (CNC) with Overweight Rating, Sets $70 PT
Centene Corporation (NYSE:CNC) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, Morgan Stanley initiated coverage on Centene with an Overweight rating and a price target of $70. Analyst Ricky Goldwasser noted that while varying permutations of policy headwinds are looming across Medicaid, this potential negative impact is disproportionately […]
Tenet Healthcare (THC) Is Up 11.18% in One Week: What You Should Know
Does Tenet Healthcare (THC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Dynamic pricing, easy comps end 22-month tonnage downturn at ArcBest
Easy comps and dynamic pricing have ArcBest back in growth mode, but yields are now lagging. The post Dynamic pricing, easy comps end 22-month tonnage downturn at ArcBest appeared first on FreightWaves.
Platinum Extends Surge to Highest Since 2021 as Market Tightens
(Bloomberg) -- Platinum extended its surge as the market for the precious metal strains under signs of severe tightness.Most Read from BloombergNext Stop: Rancho Cucamonga!Where Public Transit Systems Are Bouncing Back Around the WorldTrump Said He Fired the National Portrait Gallery Director. She’s Still There.NYC Mayoral Candidates All Agree on Building More Housing. But Where?US Housing Agency Vulnerable to Fraud After DOGE Cuts, Documents WarnSpot prices jumped as much as 4.6%, following las
Fast-paced Momentum Stock Tenet (THC) Is Still Trading at a Bargain
Tenet (THC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
6 takeaways from Michelle Bowman’s first speech as Fed vice chair
Following her confirmation, Bowman laid out plans to unravel some of the rules put in place since Dodd-Frank to better tailor them to institutions of varying sizes.
Mentions: ARCB
Should Value Investors Buy Tenet Healthcare (THC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tenet Healthcare (THC) is a Top-Ranked Momentum Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Tenet Healthcare (THC) Stock Declines While Market Improves: Some Information for Investors
Tenet Healthcare (THC) reachead $169.89 at the closing of the latest trading day, reflecting a -1.13% change compared to its last close.
Dan Ives, Analyst Known for Pink Blazers, Gets an AI ETF
- The Dan IVES Wedbush AI Revolution ETF launched with $1M in assets. - Wedbush’s first ETF focuses on big AI names including Microsoft, Nvidia and Broadcom. - The fund was little-changed in its first day of trading.
150 ESG ETFs Renamed in Response to New ESMA Naming Rules
- Advocacy groups described the renaming as ‘semantic tricks.’ - Meanwhile, some professional investors have taken a more sanguine view.
H.C. Wainwright Initiates Coverage of NeuroPace (NPCE) With Buy Rating
On May 28, H.C. Wainwright analyst Yi Chen initiated coverage of NeuroPace, Inc. (NASDAQ:NPCE) with a Buy rating and a price target of $18. The rating comes after the company released preliminary results for one-year data in NAUTILUS study. On May 27, the company announced key results from its NAUTILUS study, the first clinical trial […]
H.C. Wainwright Lowers Invivyd (IVVD) PT to $5 Amid Q1 2025 Revenue Shortfall
On Wednesday, H.C. Wainwright analyst Matthew Hedberg adjusted the price target on Invivyd Inc. (NASDAQ:IVVD) from $10 to $5, while maintaining a Buy rating. This revision follows a revenue shortfall in Q1 2025. Despite this, H.C. Wainwright believes that Invivyd is transitioning from a company solely focused on COVID-19 to a broader antibody-based infectious disease […]
Tenet Healthcare Corporation (THC) Has Jim Cramer Seriously Worried Due To Medicaid Cutback
We recently published a list of Jim Cramer Says “We Have No Idea What’s Really Going To Happen” and Discusses These 12 Stocks. In this article, we are going to take a look at where Tenet Healthcare Corporation (NYSE:THC) stands against other stocks that Jim Cramer discusses. Tenet Healthcare Corporation (NYSE:THC) is one of the […]
Mentions: UHS
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
There Is No (Convenient) Alternative
Downgrades sound scary, but the U.S. is still the best place for investors to put money to work.
Tenet Healthcare (THC) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.